Chaomin Wu
Impact in
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
- Plant-based Medicinal Research
-
- Traditional Chinese Medicine Studies
- Andrographolide Research and Applications
Papers in
-
- Respiratory Support and Mechanisms 2
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Yuanlin Song (3 shared papers)Hu Zhou (1 shared paper)Guoxing Zhu (1 shared paper)Zhenyuan Ji (1 shared paper)Min Wang (1 shared paper)Xiaoping Shen (1 shared paper)Yunting Zhang (1 shared paper)Boli Zhang (1 shared paper)
- Journals
- The Journal of the Acoustical Society of America (2 papers)PLoS ONE (2 papers)Journal of Personalized Medicine (1 paper)Scientific Reports (1 paper)Annals of Palliative Medicine (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Chaomin Wu
16 papers receiving 777 citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Pharmacology 152
- Complementary and alternative medicine 130
- Infectious Diseases 274
- Neurology 135
- Drug Discovery 1
Countries citing papers authored by Chaomin Wu
This map shows the geographic impact of Chaomin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaomin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaomin Wu more than expected).
Fields of papers citing papers by Chaomin Wu
This network shows the impact of papers produced by Chaomin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaomin Wu. The network helps show where Chaomin Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chaomin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial Hit paper breakdown → | 2020 | 338 |
| 2 | 2020 | 139 | |
| 3 | 2012 | 119 | |
| 4 | 2016 | 63 | |
| 5 | 2015 | 33 | |
| 6 | 2020 | 19 | |
| 7 | 2015 | 17 | |
| 8 | 2016 | 12 | |
| 9 | 2017 | 10 | |
| 10 | 2021 | 10 | |
| 11 | 2024 | 10 | |
| 12 | 2016 | 8 | |
| 13 | 2019 | 7 | |
| 14 | 2021 | 4 | |
| 15 | 2024 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 1997 | 1 | |
| 18 | 1996 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2011 | 0 |
About Chaomin Wu
Chaomin Wu is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Surgery, Neurology and Physiology, having authored 20 papers that have together received 796 indexed citations. Recurring topics across this work include Long-Term Effects of COVID-19 (3 papers), COVID-19 Clinical Research Studies (3 papers), Phonetics and Phonology Research (2 papers), Natural product bioactivities and synthesis (2 papers), Respiratory Support and Mechanisms (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Spine and Intervertebral Disc Pathology (1 paper) and Transcranial Magnetic Stimulation Studies (1 paper). The work is most often cited by research in Pharmacology (152 citations), Complementary and alternative medicine (130 citations), Infectious Diseases (274 citations), Neurology (135 citations) and Drug Discovery (1 citation). Chaomin Wu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yuanlin Song, Hu Zhou, Guoxing Zhu, Zhenyuan Ji, Min Wang, Xiaoping Shen, Yunting Zhang, Boli Zhang, Wei‐jie Guan and Xingwang Li. Their work appears in journals such as The Journal of the Acoustical Society of America, PLoS ONE, Journal of Personalized Medicine, Scientific Reports and Annals of Palliative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.